Virpax Pharmaceuticals (VRPX) Institutional Ownership $0.40 +0.05 (+14.71%) As of 03:15 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Virpax Pharmaceuticals (NASDAQ:VRPX)CurrentInstitutional OwnershipPercentage32.23%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.99MNumber ofInstitutional Sellers(last 12 months)0 Get VRPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virpax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VRPX Institutional Buying and Selling by Quarter Virpax Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/10/2024Garden State Investment Advisory Services LLC57,300$40K0.0%N/A1.172% 11/15/2024Garden State Investment Advisory Services LLC57,300$40K0.0%N/A1.172% 11/15/2023Sabby Management LLC292,790$234K0.2%-26.8%2.500% 5/13/2022Warberg Asset Management LLC17,710$39K0.0%N/A0.151% 11/17/2021Altium Capital Management LP271,846$1.31M0.3%N/A2.320% 11/16/2021National Asset Management Inc.18,600$90K0.0%N/A0.159% 11/2/2021Cambridge Investment Research Advisors Inc.19,420$93K0.0%N/A0.166% 9/17/2021Virtu Financial LLC23,625$107K0.0%N/A0.468% 8/16/2021Sabby Management LLC154,737$704K0.1%-22.6%3.120% 8/12/2021Saltoro Capital LP17,615$80K0.0%-34.8%0.355% 5/14/2021HN Saltoro Capital LP27,000$127K0.0%N/A0.546% (Data available from 1/1/2016 forward) VRPX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VRPX shares? During the previous two years, the following institutional investors and hedge funds held shares of Virpax Pharmaceuticals shares: Sabby Management LLC ($234K), Garden State Investment Advisory Services LLC ($40K).Learn more on Virpax Pharmaceuticals' institutional investors. What percentage of Virpax Pharmaceuticals' stock is owned by institutional investors? 32.23% of Virpax Pharmaceuticals' stock is owned by institutional investors. Learn more on VRPX's institutional investor holdings. Which institutional investors have been buying Virpax Pharmaceuticals' stock? The following institutional investors have purchased Virpax Pharmaceuticals' stock in the last 24 months: Garden State Investment Advisory Services LLC ($114.60K). How much institutional buying is happening at Virpax Pharmaceuticals? Institutional investors have bought a total of 114,600 shares in the last 24 months. This purchase volume represents approximately $1.99M in transactions. Related Companies PTPI Major Shareholders HEPA Major Shareholders ATXI Major Shareholders SYRS Major Shareholders VIRX Major Shareholders NCNA Major Shareholders VINC Major Shareholders SMFL Major Shareholders NVO Major Shareholders NVS Major Shareholders This page (NASDAQ:VRPX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRPX Stock Alerts